Search Results 1761-1770 of 17826 for Substance+dependence
... drug, during the study therapy (including dose interruptions), and for 28 days after discontinuation of the study or longer as required by local guidelines.
By condition, treatment or drug name. Search tips. Device Evaluation for Point of Care Anticoagulation Testing. Print details. Share; Facebook · Twitter.
Received an investigational drug within 1 month prior to dosing; Patients with an allergy to iodine. Female subject who is pregnant or breastfeeding; In the ...
Participating in another investigational drug or device study that may conflict with the objectives, follow-up or testing of this study;; Conditions likely ...
The failed or intolerant therapy must include corticosteroids and at least one other drug. Candidates can be adults and children over the age of 6 ...
Rochester, Minn. The purpose of this study is test the effectiveness of the senolytic drug (Fisetin) in reducing senescent cell abundance in blood in elderly ...
Cautious optimism for early results of new Alzheimer's drug featured image. Featured News. Cautious optimism for early results of new Alzheimer's drug. Ian ...
By condition, treatment or drug name. Search tips. Erlotinib Hydrochloride and ... drug(s); Patients with known human immunodeficiency virus (HIV) disease ...
... drug or completely abstain from heterosexual intercourse. Kidney transplant recipients (living and deceased donors) who received a transplant in the last 3 ...
The purpose of this study is to test any good and bad effects of adding the drug Blinatumomab to different doses of standard combination of chemotherapy drugs.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.